Undoctored vault view

Vertex is disappointed that the Pharmacology and Therapeutics Advisory Committee (PTAC) has recommended Trikafta be listed with a medium priority

As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) met yesterday to discuss the latest evidence on the Omicron variant of concern, including its sublineages BA.1 and BA.2

Ten thousand allied, public health, scientific and technical professionals who work in DHBs have voted overwhelmingly to strike

Only a tiny percentage of New Zealanders who use cannabis for medicinal purposes are accessing the product through legal channels, new analysis by the NZ Drug Foundation shows

Pharmac is releasing meeting records of its COVID-19 Treatments Advisory Group and seeking feedback on the patient access criteria for two COVID-19 antiviral treatments – molnupiravir (branded as Lagevrio) and nirmatrelvir with ritonavir (Paxlovid)

Too many people are dying from preventable overdoses and Aotearoa lacks the interventions that could stop them, a new report being released this week by the NZ Drug Foundation shows

New Zealand’s largest medicinal cannabis summit, including a one-day Healthcare Professionals Forum, is about to kick off, with MedCan 2022 taking place virtually this Thursday and Friday – 10 and 11 February

New Zealand’s fastest growing pharmacy group, Chemist Warehouse, is pleased to announce its partnership of all five New Zealand Super Rugby teams in a long term commitment to Rugby, kicking off with this year’s hotly anticipated 2022 Super Rugby Pacific season

The latest data from the UK Health Security Agency (UKHSA) shows that boosters significantly reduce the risk of death with Omicron

The ninety percent first dose milestone was today achieved by Māori across Aotearoa says Patricia Joseph, Equity Group Manager at Ministry of Health’s Immunisation Programme